Prof Harry Sumnall

Journal article

McKay M, Agus A, Cole J, Doherty P, Foxcroft D, Harvey S, Murphy L, Percy A, Sumnall H. 2018. Steps Towards Alcohol Misuse Prevention Programme (STAMPP): a school-based and community-based cluster randomised controlled trial. BMJ Open, 8 :e019722-e019722 >DOI >Link

Wells KE, Morgan G, Worrell FC, Sumnall H, McKay MT. 2018. The influence of time attitudes on alcohol-related attitudes, behaviors and subjective life expectancy in early adolescence: A longitudinal examination using mover-stayer latent transition analysis INTERNATIONAL JOURNAL OF BEHAVIORAL DEVELOPMENT, 42 :93-105 >DOI >Link

Atkinson AM, Sumnall H. 2017. ‘Isn’t it mostly girls that do pre-drinks really?’ Young men and women’s accounts of pre-loading in the UK Drugs: Education, Prevention, and Policy, >DOI

Holmes J, Sumnall H. 2017. On risk in addiction science, policy and debate ADDICTION, 112 :1895-1897 >DOI >Link

Sumnall H, Agus A, Cole JC, Doherty P, Foxcroft D, Harvey S, McKay M, Murphy L, Percy A. 2017. Steps Towards Alcohol Misuse Prevention Programme (STAMPP): a school- and community-based cluster randomised controlled trial Public Health Research, 5

Giles EL, Coulton S, Deluca P, Drummond C, Howel D, Kaner E, McColl E, McGovern R, Scott S, Stamp E, Sumnall H, Tate L, Todd L, Vale L, Albani V, Boniface S, Ferguson J, Frankham J, Gilvarry E, Hendrie N, Howe N, J McGeechan G, Stanley G, Newbury-Birch D. 2016. Multicentre individual randomised controlled trial of screening and brief alcohol intervention to prevent risky drinking in young people aged 14-15 in a high school setting (SIPS JR-HIGH): Study protocol BMJ Open, 6 >DOI

Atkinson AM, Sumnall HR. 2016. 'If I don't look good, it just doesn't go up': A qualitative study of young women's drinking cultures and practices on Social Network Sites INTERNATIONAL JOURNAL OF DRUG POLICY, 38 :50-62 >DOI >Link

Harvey SA, McKay MT, Sumnall HR. 2016. Adolescents' reflections on school-based alcohol education in the United Kingdom: education as usual compared with a structured harm reduction intervention JOURNAL OF SUBSTANCE USE, 21 :640-645 >DOI >Link

Timpson H, Eckley L, Sumnall H, Pendlebury M, Hay G. 2016. “Once you’ve been there, you’re always recovering”: exploring experiences, outcomes, and benefits of substance misuse recovery Drugs and Alcohol Today, 16 :29-38 >DOI >Link

Bellis MA, Hughes K, Jones L, Morleo M, Nicholls J, McCoy E, Webster J, Sumnall H. 2015. Holidays, celebrations, and commiserations: measuring drinking during feasting and fasting to improve national and individual estimates of alcohol consumption BMC Medicine, 13 :113-113 >DOI

Faggiano F, Allara E, Giannotta F, Molinar R, Sumnall H, Wiers R, Michie S, Collins L, Conrod P. 2014. Europe Needs a Central, Transparent, and Evidence-Based Approval Process for Behavioural Prevention Interventions PLOS MEDICINE, 11 >DOI >Link

Gabrhelík R, Calafat A, Sumnall H, Brenza J, Juan M, Mendes F, Karlsson Rådelius E, Talić S, Csémy L, Brotherhood A, Duch M, Jurystova L, Košir M, Magalhaes C, Ramstedt M, Skarstrand E. 2014. (Self)organizing potential of European parents to prevent children from alcohol, tobacco and other drug use Adiktologie, 14 :116-124

McKay M, Sumnall H, McBride N, Harvey S. 2014. The differential impact of a classroom-based, alcohol harm reduction intervention, on adolescents with different alcohol use experiences: A multi-level growth modelling analysis JOURNAL OF ADOLESCENCE, 37 :1057-1067 >DOI >Link

Lightowlers C, Sumnall H. 2014. A violent mix? The association between concurrent alcohol and cocaine use and violence amongst young people in England and Wales DRUGS-EDUCATION PREVENTION AND POLICY, 21 :131-139 >DOI >Link

McBride N, McKay M, Sumnall H. 2013. SHAHRP: School health and alcohol harm reduction project - Developments in Australia and the UK Education and Health, 31 :79-83

Fernandez-Hermida J-R, Calafat A, Becona E, Secades-Villa R, Juan M, Sumnall H. 2013. CROSS-NATIONAL STUDY ON FACTORS THAT INFLUENCE PARENTS' KNOWLEDGE ABOUT THEIR CHILDREN'S ALCOHOL USE JOURNAL OF DRUG EDUCATION, 43 :155-172 >DOI

Sumnall HR. 2013. The New Zealand new psychoactive substances regime - A step in the right direction, but questions still remain Journal of Psychopharmacology, 27 :1076-1078 >DOI

Fernie G, Peeters M, Gullo MJ, Christiansen P, Cole JC, Sumnall H, Field M. 2013. Multiple behavioural impulsivity tasks predict prospective alcohol involvement in adolescents Addiction, 108 :1916-1923 >DOI

Becoña E, Martínez U, Calafat A, Fernández-Hermida JR, Juan M, Sumnall H, Mendes F, Gabrhelík R. 2013. Parental permissiveness, control, and affect and drug use among adolescents Psicothema, 25 :292-298 >DOI

McKay MT, Percy A, Goudie AJ, Sumnall HR, Cole JC. 2012. The Temporal Focus Scale: factor structure and association with alcohol use in a sample of Northern Irish school children. J Adolesc, 35 :1361-1368 >DOI >Link

McKay MT, Cole JC, Sumnall HR, Goudie AJ. 2012. Framing health messages for adolescents: Should we use objective time periods, temporal benchmarks, or both? Journal of Youth Studies, 15 :351-368 >DOI

McKay MT, McBride NT, Sumnall HR, Cole JC. 2012. Reducing the harm from adolescent alcohol consumption: Results from an adapted version of SHAHRP in Northern Ireland Journal of Substance Use, 17 :98-121 >DOI

McKay MT, Ballantyne N, Goudie AJ, Sumnall HR, Cole JC. 2012. "Here for a good time, not a long time": Decision-making, future consequences and alcohol use among Northern Irish adolescents Journal of Substance Use, 17 :1-18 >DOI

McKay MT, Sumnall HR, Cole JC, Percy A. 2012. Self-esteem and self-efficacy: Associations with alcohol consumption in a sample of adolescents in Northern Ireland Drugs: Education, Prevention and Policy, 19 :72-80 >DOI

Sumnall HR, Measham F, Brandt SD, Cole JC. 2011. Salvia divinorum use and phenomenology: results from an online survey. J Psychopharmacol, 25 :1496-1507 >DOI >Link

Goudie AJ, Gullo MJ, Rose AK, Christiansen P, Cole JC, Field M, Sumnall H. 2011. Nonaddictive instrumental drug use: Theoretical strengths and weaknesses. Behav Brain Sci, 34 :314-315 >DOI >Link

Sumnall HR, Evans-Brown M, McVeigh J. 2011. Social, policy, and public health perspectives on new psychoactive substances. Drug Test Anal, 3 :515-523 >DOI >Link

Atkinson AM, Sumnall H, Measham F. 2011. Depictions of alcohol use in a UK Government partnered online social marketing campaign: Hollyoaks 'The Morning after the night before' DRUGS-EDUCATION PREVENTION AND POLICY, 18 :454-467 >DOI

McKay MT, Cole JC, Sumnall H. 2011. Teenage thinking on teenage drinking: 15- to 16-year olds' experiences of alcohol in Northern Ireland DRUGS-EDUCATION PREVENTION AND POLICY, 18 :323-332 >DOI >Link

McKay MT, Cole JC, Field M, Goudie AJ, Sumnall H. 2011. What differentiates adolescent problematic drinkers from their peers? Results from a cross-sectional study in Northern Irish school children Drugs: Education, Prevention and Policy, 3 :187-199

Downing J, Jones L, Bates G, Sumnall H, Bellis MA. 2011. A systematic review of parent and family-based intervention effectiveness on sexual outcomes in young people. Health Educ Res, 26 :808-833 >DOI >Link

Brandt SD, Sumnall HR, Measham F, Cole J. 2010. The confusing case of NRG-1 BMJ (Online), 341 :62 >DOI

Montgomery C, Field M, Atkinson AM, Cole JC, Goudie AJ, Sumnall HR. 2010. Effects of alcohol preload on attentional bias towards cocaine-related cues. Psychopharmacology (Berl), 210 :365-375 >DOI >Link

Brandt SD, Sumnall HR, Measham F, Cole J. 2010. Second generation mephedrone The confusing case of NRG-1 BRITISH MEDICAL JOURNAL, 341 >DOI >Link

Brandt SD, Sumnall HR, Measham F, Cole J. 2010. Analyses of second-generation 'legal highs' in the UK: initial findings. Drug Test Anal, 2 :377-382 >DOI >Link

Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J. 2010. Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones. Drug Test Anal, >DOI

Woolfall K, Sumnall H. 2010. Evaluating interventions for children of substance using parents: A review of outcome measures ADDICTION RESEARCH & THEORY, 18 :326-343 >DOI >Link

Sumnall H, Bellis MA, Hughes K, Calafat A, Juan M, Mendes F. 2010. A choice between fun or health? Relationships between nightlife substance use, happiness, and mental well-being JOURNAL OF SUBSTANCE USE, 15 :89-104 >DOI >Link

Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA. 2010. Optimal provision of needle and syringe programmes for injecting drug users: A systematic review. Int J Drug Policy, 21 :335-342 >DOI >Link

Sumnall H. 2009. Regulation of synthetic cannabinoids. Lancet, 374 :1595 >DOI >Link

Sumnall HR, Woolfall K, Edwards S, Cole JC, Beynon CM. 2008. Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB). Drug Alcohol Depend, 92 :286-290 >DOI >Link

Sumnall HR, Woolfall K, Cole J, Mackridge A, McVeigh J. 2008. NICE guidance on ADHD. Diversion and abuse of methylphenidate in light of new guidance BMJ, 337 :a2287 >Link

Sumnall HR, Bellis MA. 2007. Can health campaigns make people ill? The iatrogenic potential of population-based cannabis prevention JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 61 :930-931 >DOI

Sumnall HR, Beynon CM, Conchie SM, Riley SCE, Cole JC. 2007. An investigation of the subjective experiences of sex after alcohol or drug intoxication. J Psychopharmacol, 21 :525-537 >DOI >Link

Goudie AJ, Cole JC, Sumnall HR. 2007. Olanzapine and JL13 induce cross-tolerance to the clozapine discriminative stimulus in rats Behav.Pharmacol., 18 :9-17 >Link

Goudie AJ, Sumnall HR, Field M, Clayton H, Cole JC. 2007. The effects of price and perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases Drug Alcohol Depend., 89 :107-115 >Link

Goudie AJ, Cooper GD, Cole JC, Sumnall HR. 2007. Cyproheptadine resembles clozapine in vivo following both acute and chronic administration in rats J.Psychopharmacol., 21 :179-190 >Link

Cole JC, Field M, Sumnall HR, Goudie AJ. 2007. Potentiation of olanzapine substitution in rats discriminating clozapine by the D2/3 agonist quinpirole Behav.Pharmacol., 18 :185-190 >Link

Goudie AJ, Cole JC, Sumnall HR. 2007. Olanzapine withdrawal/discontinuation-induced hyperthermia in rats Prog.Neuropsychopharmacol.Biol.Psychiatry, 31 :1500-1503 >Link

Beynon CM, Sumnall HR, McVeigh J, Cole JC, Bellis MA. 2006. The ability of two commercially available quick test kits to detect drug-facilitated sexual assault drugs in beverages. Addiction, 101 :1413-1420 >DOI >Link

Beynon C, Sumnall HR, McVeigh J, Cole JC, Bellis MA. 2006. Drink detective: Comments on the manufacturer's response ADDICTION, 101 :1395-1395 >DOI

Cole JC, Michailidou K, Jerome L, Sumnall HR. 2006. The effects of stereotype threat on cognitive function in ecstasy users J.Psychopharmacol., 20 :518-525 >Link

Sumnall HR, Cole JC, Jerome L. 2006. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy J.Psychopharmacol., 20 :670-682 >Link

Field M, Santarcangelo M, Sumnall H, Goudie A, Cole J. 2006. Delay discounting and the behavioural economics of cigarette purchases in smokers: the effects of nicotine deprivation. Psychopharmacology (Berl), 186 :255-263 >DOI >Link

Sumnall HR, Bellis MA, Cole JC, Mcveigh J. 2005. Crack-cocaine injection: A retrospective analysis of clients in Merseyside specialist drug treatment agencies DRUGS-EDUCATION PREVENTION AND POLICY, 12 :213-221 >DOI >Link

Gamma A, Jerome L, Liechti ME, Sumnall HR. 2005. Is ecstasy perceived to be safe? A critical survey Drug Alcohol Depend., 77 :185-193 >Link

Cole JC, Sumnall HR, Smith GW, Rostami-Hodjegan A. 2005. Preliminary evidence of the cardiovascular effects of polysubstance misuse in nightclubs J.Psychopharmacol., 19 :67-70 >Link

Sumnall HR, Cole JC. 2005. Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis J.Psychopharmacol., 19 :84-92 >Link

Sumnall HR, Jerome L, Doblin R, Mithoefer MC. 2004. Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450 Psychopharmacology (Berl), 171 :229-230 >Link

Sumnall HR, O'Shea E, Marsden CA, Cole JC. 2004. The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test Pharmacol.Biochem.Behav., 77 :805-814 >Link

Sumnall HR, Wagstaff GF, Cole JC. 2004. Self-reported psychopathology in polydrug users J.Psychopharmacol., 18 :75-82 >Link

Sumnall HR, Tyler E, Wagstaff GF, Cole JC. 2004. A behavioural economic analysis of alcohol, amphetamine, cocaine and ecstasy purchases by polysubstance misusers Drug Alcohol Depend., 76 :93-99 >Link

Cole JC, Sumnall HR, O'Shea E, Marsden CA. 2003. Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse Psychopharmacology (Berl), 166 :383-390 >Link

Cole JC, Sumnall HR. 2003. Altered states: the clinical effects of Ecstasy Pharmacol.Ther., 98 :35-58 >Link

Cole JC, Sumnall HR. 2003. The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA) Neurosci.Biobehav.Rev., 27 :199-217 >Link

Cole J, Sumnall H, Grob C. 2002. Sorted: Ecstasy facts and fiction Psychologist, 15 :464-467

Cole J, Sumnall H, Grob C. 2002. Where are the casualties? Psychologist, 15 :474

Cole JC, Sumnall HR. 2002. The BDI of the beholder J.Psychopharmacol., 16 :103 >Link

Cole JC, Sumnall HR, Wagstaff GF. 2002. What is a dose of ecstasy? J.Psychopharmacol., 16 :189-190 >Link

Cole JC, Sumnall HR, Wagstaff GF. 2002. Methodological problems with ecstasy and the SCL-90 Psychopharmacology (Berl), 162 :215-217 >Link

Cole JC, Bailey M, Sumnall HR, Wagstaff GF, King LA. 2002. The content of ecstasy tablets: implications for the study of their long-term effects Addiction, 97 :1531-1536 >Link

Cole J, Sumnall H, Grob C. 2002. Where are the casualties? Response PSYCHOLOGIST, 15 :474-474

Pennington B, Collins B, Leigh S, Martin A, Owen L, Fischer A, Sumnall H, Bates G. The cost-effectiveness of seven behavioural interventions to prevent drug misuse in vulnerable populations International Journal of Drug Policy,

McKay MT, Sumnall H, Harvey SA, Cole JC. Perceptions of school-based alcohol education by educational and health stakeholders: “Education as usual” compared to a randomised controlled trial Drugs: Education, Prevention, and Policy, >DOI

Atkinson A, Ross-Houle KM, Begley E, Sumnall H. An exploration of alcohol advertising on social networking sites: an analysis of content, interactions and young people’s perspectives ADDICTION RESEARCH & THEORY, >DOI

Atkinson AM, Kirton AW, Sumnall HR. The gendering of alcohol in consumer magazines: an analysis of male and female targetted publications Journal of Gender Studies, 21 :365-386 >DOI

Atkinson AM, Sumnall H, Bellis MA. Young people's perspective on the portrayal of alcohol on televison: findings from a focus group study Addiction, Research and Theory,

Other

Sumnall H. 2017. The harm reduction impact of cryptomarkets: inequality and opportunity Addiction, >DOI

Chatwin C, Measham F, O'Brien K, Sumnall H. 2017. New drugs, new directions? Research priorities for new psychoactive substances and human enhancement drugs. Int J Drug Policy, 40 :1-5 >DOI >Link

Simkhada P, Poudel AN, Simkhada B, Sumnall H, Jones L, Bista S, McVeigh J, Gaidhane A, Zahiruddin QS, Chowdhury ME, Bhuiyan MBAS, Iliyasu Z, Pant PR, Kurmi O, Hill R, Van Teijlingen E, Regmi PR. 2017. Need and scope of global partnership on public health research Journal of Datta Meghe Institute of Medical Sciences University, 11 :260-262

Stevens A, Fortson R, Measham F, Sumnall H. 2015. Legally flawed, scientifically problematic, potentially harmful: The UK Psychoactive Substance Bill INTERNATIONAL JOURNAL OF DRUG POLICY, 26 :1167-1170 >DOI >Link

Report

Bates G, Jones L, Maden M, Cochrane M, Pendlebury M, Sumnall HS. 2017. The effectiveness of interventions related to the use of illicit drugs: prevention, harm reduction, treatment and recovery. A ‘review of reviews’. The effectiveness of interventions related to the use of illicit drugs: prevention, harm reduction, treatment and recovery. A ‘review of reviews’. HRB Drug and Alcohol Evidence Review 5

Atkinson A, Pirona A, Begley E, Sumnall H. 2016. Health responses to new psychoactive substances >DOI

Eckley L, Harrison R, Cochrane MA, Pendlebury M, Sumnall H, Timpson H. 2016. Evaluation of Four Recovery Communities across England: Interim report for the Give it Up project

Atkinson A, Ross KM, Begley E, Sumnall H. 2015. Constructing alcohol identities: the role of Social Network Sites (SNS) in young peoples’ drinking cultures

Jones L, Bates G, Bellis M, Beynon C, Duffy P, Evans-Brown M, Mackridge A, McCoy E, Sumnall H, McVeigh J. 2011. A summary of the health harms of drugs >Link

Quigg ZA, Atkinson A, Hughes K, Bellis M, Sumnall H, Syed Q. 2009. Interpersonal violence and illicit drugs

Warering M, McVeigh J, Sumnall H. 2008. Young People and Cannabis use in Liverpool. >Link

Woodfall K, Sumnall H, McVeigh J. 2008. Addressing the needs of children of substance using parents: an evaluation of Families First’s Intensive Intervention Final Report. >Link

Khundakar A, Sumnall H, Marr A, McVeigh J, Bellis A. 2007. Individuals aged under 25 in contact with treatment services in the North West of England during 2005/06. >Link

Fordham R, Jones L, Sumnall H, McVeigh J, Bellis M. 2007. The economics of preventing drug use: An introduction to the issues. Richard Fordham, Lisa Jones, Harry Sumnall, Jim McVeigh and Mark Bellis >Link

Wareing M, McVeigh J, Sumnall H. 2007. Young People and Substance Misuse: Characteristics, Needs and Perception of Treatment Services of Drug Users Aged 18 to 25 in Liverpool. >Link

McGrath Y, Sumnall H, McVeigh J, Bellis M. 2006. Drug use prevention among young people: a review of reviews. >Link

Jones L, Sumnall H, Witty K, Wareing M, McVeigh J, Bellis M. 2006. A review of community-based interventions to reduce stance misuse among vulnerable and disadvantaged young people. >Link

Sumnall H, McGrath Y, McVeigh J, Burrell K, Wilkinson L, Bellis M. 2006. Drug use prevention among young people Evidence into practice briefing. >Link

Sumnall H, McGrath Y, McVeigh J, Burrell K, Wilkinson L, Bellis M, Reid D. 2006. Drug use prevention among young people Evidence into practice briefing. >Link

Burrell K, Sumnall H, Witty C, McVeigh J. 2006. Alcohol Brief Intervention >Link

Jones L, Sumnall H, Burrell K, McVeigh J, Bellis M. 2006. Universal Drug Prevention. >Link

Jones L, Sumnall H, Burrell K, McVeigh J, Bellis M. 2006. Universal Drug Prevention - Fact Sheets >Link

McGrath Y, Sumnall H, Edmonds K, McVeigh J, Bellis M. 2006. Review of grey literature on drug prevention among young people. >Link

McGrath Y, Sumnall H, Burrell K, McVeigh J, Bellis M. 2006. Review of grey literature on drug prevention among young people Review Summary. >Link

Sumnall H, Jones L, Burrell K, Witty K, McVeigh J, Bellis M. 2006. Annual review of Drug Prevention The National Collaborating Centre for Drug Prevention. >Link

Sumnall H, Cook L, McGrath Y, Wilkinson L, McVeigh J, Bellis M, Burrell K. 2005. Drug Prevention Quarterly - April 2005. >Link

Burrell K, Sumnall H, McVeigh J, Bellis M. 2005. Drug Prevention vulnerable young people. >Link

Burrell K, Sumnall H, McVeigh J, Bellis M. 2005. Drug Prevention - Fact Sheet >Link

Sumnall H, Burrell K, Jones L, Wilkinson L, McVeigh J, Bellis M. 2005. Drug Prevention Quarterly September 2005. >Link

BURRELL K, Jones L, SUMNALL H, McVeigh J, Bellis M. 2005. Tiered approach to Drug Prevention and treatment among young people. >Link

Cook L, McGrath Y, Wilkinson L, Sumnall H, McVeigh J, Bellis M, Burrell K. 2004. Drug Prevention Quarterly - November 2004. >Link

Editorial/letter to the editor

Simkhada P, Poudel AN, Simkhada B, Sumnall H, Jones L, Bista S, McVeigh J, Gaidhane A, Zahiruddin QS, Chowdhury ME, Bhuiyan MBAS, Iliyasu Z, Pant PR, Kurmi O, Hill R, van Teijlingen E, Regmi PR. 2016. Need and scope of global partnership on public health research Journal of Datta Meghe Institute of Medical Sciences University, 11 :202-204

Sumnall HR, Woolfall K, Cole J, Mackridge A, McVeigh J. 2008. Diversion and abuse of methylphenidate BMJ, 337 :1011

Sumnall HR, Woolfall K, Cole J, Mackridge A, McVeigh J. 2008. NICE GUIDANCE ON ADHD Diversion and abuse of methylphenidate BRITISH MEDICAL JOURNAL, 337 >DOI >Link

Chapters

Ross-Houle KM, atkinson A, SUMNALL H. 2015. The Symbolic Value of Alcohol: The importance of alcohol consumption, drinking practices and drinking spaces in classed and gendered identity construction Thurnall-Read T. Drinking Dilemmas: Space, Culture and Identity :28-44 Routledge. London 978-1-138-93114-5

Conrod P, Brotherhood A, Sumnall HR, Fagiano F, Wiers R. 2015. Drug and Alcohol Policy for European Youth: Current evidence and recommendations for integrated policies and research strategies Anderson P, Rehm J, Room R. Impact of Addictive Substances and Behaviours on Individual and Societal Well-being Oxford University Press 978-0198714002

Sumnall H, McVeigh J, Evans-Brown M. 2013. Epidemiology of use of novel psychoactive substances Dargan P, Wood D. Novel Psychoactive Substances Academic Press 9780124158160

Sumnall H, Jones L. 2009. Redefining Drug Prevention Barlow J. Substance misuse 53 :155-168 Jessica Kingsley Pub. London 9781843106968

Internet publication

Brotherhood A, Sumnall HR. 2013. European drug prevention quality standards: a quick guide >DOI

Conference publication

Field M, Fernie G, Gullo MJ, Christiansen P, Cole JC, Sumnall HR. 2012. THE RELATIONSHIP BETWEEN INHIBITORY CONTROL AND DEVELOPMENTAL CHANGES IN ADOLESCENT ALCOHOL USE ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 16th World Congress of the International-Society-for-Biomedical-Research-on-Alcoholism (ISBRA) 36 :30A-30A >Link

Sumnall HR, Cole JC. 2002. Neurotoxic MDMA attenuates the rewarding properties of ethanol but has no effect upon cocaine or other drugs of abuse JOURNAL OF PSYCHOPHARMACOLOGY, 16 :A68-A68 >Link

Sumnall HR, Cole JC. 2002. Neurotoxic MDMA attenuates the rewarding properties of ethanol but has no effect upon cocaine or other drugs of abuse JOURNAL OF PSYCHOPHARMACOLOGY, 16 :A59-A59 >Link

Cole J, Bailey M, Sumnall H, King L. 2002. The content of ecstasy tablets: Implications for their long-term effects JOURNAL OF PSYCHOPHARMACOLOGY, Summer Meeting of the British-Association-for-Psychopharmacology 16 :A60-A60

Book

Sumnall HR, Brotherhood A. 2012. Social reintegration and employment: evidence and interventions for drug users in treatment. 13 Publications Office of the European Union. Luxembourg

Brotherhood A, Sumnall HR, European Monitoring Centre for Drugs and Drug Addiction . 2011. European drug prevention quality standards: a manual for prevention professionals No 7 The Publications Office of the European Union. Luxembourg

Editorial boards:

Publication: Addictive Behaviors

External committees:

Committee name: European Society for Prevention Research (EUSPR), Organisation: EUSPR, Position: Board member

Committee name: Advisory Council on the Misuse of Drugs (ACMD), Organisation: Home Office, Position: Member, URL: https://www.gov.uk/government/organisations/advisory-council-on-the-misuse-of-drugs

External PGR Supervision - completed students:

Name of University: University of Liverpool, Award gained by the student: PhD, Thesis title: Risk and protection in Northern Irish alcohol users

Research Grants Awarded:

EMCDDA, Assistance to European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for the analysis of drug use profiles from EMCDDA Databank on surveys on drug use’, Grant value (£): 16000

Department of Health, Assessment, integration and delivery of evidence from government sponsored research on the prevention of drug misuse in a manner which maximises the implementation of evidence based practice, Grant value (£): 160000

Health Development Agency, Health Development Agency (currently National Institute of Health and Clinical Excellence) Collaborating Centre (Drug Prevention)., Grant value (£): 200000

NICE, Scoping exercise on Drugs Prevention in the Community and Server Focussed intoxication management strategies, Grant value (£): 40000

Department of Health, Work Programme on Drug Prevention Evidence Review and Dissemination, Grant value (£): 101000

British Academy, Risk perception and risk taking behaviours in non-treatment seeking drug users, Grant value (£): 7006

Liverpool D(A)AT, Young People and Substance Misuse: Characteristics, Needs and Perception of Treatment Services of Drug Users Aged 18 to 25 in Liverpool, Grant value (£): 20994

Knowsley D(A)AT, Class A drug use in Knowsley D(A)AT, Grant value (£): 14000

Wirral D(A)AT, Class A drug use in Wirral D(A)AT, Grant value (£): 28276

Preston PCT, Evaluation of Alcohol Brief Intervention, Grant value (£): 9836

NICE, Community based interventions for the reduction of substance misuse among vulnerable and disadvantaged young people. A rapid review, Grant value (£): 65007

NICE, Substance misuse interventions – fieldwork, Grant value (£): 45000

Department of Health, Evaluation of Families First, Grant value (£): 88312

AERC, A pilot intervention providing individually tailored feedback on alcohol consumption in University students, Grant value (£): 4915

Department of Health, Evaluation of projects working in High Focus Areas, Grant value (£): 98226

EMCDDA, Reference methodological package on the EMCDDA General Population Survey Indicator, Grant value (£): 10950

MRC, Inhibitory control and cue salience in alcohol abuse, Grant value (£): 283104

NICE, Perceptions of new smoking cessation interventions by young people, Grant value (£): 30000

Liverpool CitySafe, Cannabis use in Liverpool, Grant value (£): 15000

NICE, review of effectiveness and cost effectiveness of optimum provision of needle exchanges for injecting drug users, Grant value (£): 127500

Blackburn DAAT, Evidence review of YP drug services in Blackburn with Darwen, Grant value (£): 10000

Liverpool PCT, Evaluation of Operation SafeSpace, Merseyside, Grant value (£): 10000

Cheshire DAAT, Young people substance use needs assessment, Grant value (£): 10000

Roy Castle Foundation, Qualitative evaluation of service users experiences of community smoking cessation programmes, Grant value (£): 15000

NICE, Fieldwork to inform NICE guidance on optimum provision of NSPs, Grant value (£): 35000

EU Public Health Executive Agency, EU Standards in Drug prevention, Grant value (£): 284507

CHAMPS, Behavioural change interventions in Cheshire and Merseyside, Grant value (£): 25000

Liverpool, Sefton, and Salford PCTs, Health Needs Assessment in NW Prisons, Grant value (£): 35000

Wirral PCT, R&D Needs Assessment in Wirral PCT, Grant value (£): 20000

NICE, Fieldwork to inform NICE guidance on prevention of alcohol use disorders, Grant value (£): 35000

NICE, Review of effectiveness and cost effectiveness of PSHE, Grant value (£): 99000

JRF, Influence of media on transmission of drinking cultures in young people, Grant value (£): 100000

EU-DPIP, European Family Empowerment: Improving family skills to prevent alcohol and drug related problems, Grant value (£): 396000

AERC, European School Survey Project on Alcohol and Other Drugs; UK survey 2011, Grant value (£): 36000

EMCDDA, Social reintegration and reduction of social exclusion of drug users – Improving labour market participation of drug users in treatment, Grant value (£): 10000

EU, ALICE-RAP: Adolescents as customers, Grant value (£): 225000

Warrington DAAT, Public perceptions of drug use in Warrington, UK, Grant value (£): 15000

NIHR-PH, SHAHRP and TATI alcohol misuse prevention programme (STAMPP): school based randomised controlled trial, Grant value (£): 1044370

EC DG-Justice DPIP, Promoting Excellence in Drug Prevention in the EU, Grant value (£): 590956

Alcohol Research UK, Constructing alcohol identities. How young people navigate and make sense of online intoxicogenic marketing and culture, Grant value (£): 58000

ESRC, ESRC Seminar Series on New Psychoactive Substances/Human Enhancement Drugs, Grant value (£): 20000

Tameside Council, Needs Assessment of New Psychoactive Substance Use (Tameside Council, Grant value (£): 20000

National Institute for Health and Care Excellence, NICE Evidence Review (economic modelling) : drug prevention, Grant value (£): 60000